LEASE AGREEMENTLease Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
LORRELLE S. JOHNSON and SHARON L. JOHNSON, of 3094 North Main Street Extension, Jamestown, New York 14701, hereinafter referred to as “Johnson,”
SUBLEASE AGREEMENTSublease Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
THIS SUBLEASE AGREEMENT, made and entered into on December 1, 2007 by and between 60 PINEVIEW LLC, organized and existing under and by virtue of the laws of the state of New York having its principal office at 60 Pineview Drive, Amherst, New York 14228 (the “Sublessor”) and IMMCO DIAGNOSTICS, INC., organized and existing under and by virtue of the laws of the State of New York with its address at 60 Pineview Drive, Amherst, New York 14228 (the “Sublessee”).
PATENT LICENSE AGREEMENTPatent License Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • Massachusetts
This PATENT LICENSE AGREEMENT (the “Agreement”) is entered into as of August 3, 2006, by and between Inverness Medical Innovations, Inc., a corporation organized and existing under the laws of Delaware (hereinafter called “Inverness”), and Trinity Biotech PLC, a corporation organized and existing under the laws of the Republic of Ireland (hereinafter called “Trinity”).
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT-NONEXCLUSIVE COVER PAGEPatent License Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • District of Columbia
US Patent 8,148,057, entitled, “Immunoassays and Devices for Detection of Anti-Lipoidal Antibodies”, issued 4/3/2012, claiming priority to US Provisional Patent Application No. 60/693,120, filed 6/21/2005, inventor, Arnold Castro.
BUSINESS & ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • England
PATENT LICENSE AGREEMENTAgreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • Texas
THIS AGREEMENT (“Agreement”) is between the Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, and Trinity Biotech, Incorporated, a Missouri corporation having a principal place of business located at1930 Business Center Drive, Saint Louis, Missouri 63114, USA (“Trinity”).
THIS INDENTURE made the 20 day of December 2007 B E T W E E NTrinity Biotech PLC • March 25th, 2015 • In vitro & in vivo diagnostic substances
RONAN O’CAOIMH of Glencarrig, Delgany, County Wicklow and JIM WALSH of Ardvana, The Hill, Monkstown, Co. Dublin (hereinafter called “the Landlord”) which expression shall where the context so admits include their respective successors in title, executors, administrators and assigns) of the one part TRINITY BIOTECH MANUFACTURING LIMITED having its registered office at IDA Business park, Bray, County Wicklow (hereinafter called “the Tenant” which expression shall where the context so admits include its successors in title and permitted assigns) of the other part and
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT-NONEXCLUSIVE COVER PAGEPatent License Agreement • March 25th, 2015 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) and/or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), Appendix E (Benchmarks), Appendix F (Commercial Development Plan) and Appendix G (U.S. Manufacturing Waiver). The Parties to this Agreement are:
